1 Study Coverage 1.1 End-Stage Kidney Disease Treatment Product Introduction 1.2 Market by Type 1.2.1 Global End-Stage Kidney Disease Treatment Market Size Growth Rate by Type 1.4.2 MK-3866 1.4.3 Pacritinib 1.2.4 Sanguinate 1.2.5 Tesidolumab 1.2.6 Others 1.3 Market by Application 1.3.1 Global End-Stage Kidney Disease Treatment Market Size Growth Rate by Application 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global End-Stage Kidney Disease Treatment Sales Estimates and Forecasts 2016-2027 2.2 Global End-Stage Kidney Disease Treatment Revenue Estimates and Forecasts 2016-2027 2.3 Global End-Stage Kidney Disease Treatment Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top End-Stage Kidney Disease Treatment Regions by Sales 2.4.1 Global Top End-Stage Kidney Disease Treatment Regions by Sales (2016-2021) 2.4.2 Global Top End-Stage Kidney Disease Treatment Regions by Sales (2022-2027) 2.5 Global Top End-Stage Kidney Disease Treatment Regions by Revenue 2.5.1 Global Top End-Stage Kidney Disease Treatment Regions by Revenue (2016-2021) 2.5.2 Global Top End-Stage Kidney Disease Treatment Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global End-Stage Kidney Disease Treatment Sales by Manufacturers 3.1.1 Global Top End-Stage Kidney Disease Treatment Manufacturers by Sales (2016-2021) 3.1.2 Global Top End-Stage Kidney Disease Treatment Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by End-Stage Kidney Disease Treatment Sales in 2020 3.2 Global End-Stage Kidney Disease Treatment Revenue by Manufacturers 3.2.1 Global Top End-Stage Kidney Disease Treatment Manufacturers by Revenue (2016-2021) 3.2.2 Global Top End-Stage Kidney Disease Treatment Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by End-Stage Kidney Disease Treatment Revenue in 2020 3.3 Global End-Stage Kidney Disease Treatment Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global End-Stage Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global End-Stage Kidney Disease Treatment Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global End-Stage Kidney Disease Treatment Sales by Type 4.1.1 Global End-Stage Kidney Disease Treatment Historical Sales by Type (2016-2021) 4.1.2 Global End-Stage Kidney Disease Treatment Forecasted Sales by Type (2022-2027) 4.1.3 Global End-Stage Kidney Disease Treatment Sales Market Share by Type (2016-2027) 4.2 Global End-Stage Kidney Disease Treatment Revenue by Type 4.2.1 Global End-Stage Kidney Disease Treatment Historical Revenue by Type (2016-2021) 4.2.2 Global End-Stage Kidney Disease Treatment Forecasted Revenue by Type (2022-2027) 4.2.3 Global End-Stage Kidney Disease Treatment Revenue Market Share by Type (2016-2027) 4.3 Global End-Stage Kidney Disease Treatment Price by Type 4.3.1 Global End-Stage Kidney Disease Treatment Price by Type (2016-2021) 4.3.2 Global End-Stage Kidney Disease Treatment Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global End-Stage Kidney Disease Treatment Sales by Application 5.1.1 Global End-Stage Kidney Disease Treatment Historical Sales by Application (2016-2021) 5.1.2 Global End-Stage Kidney Disease Treatment Forecasted Sales by Application (2022-2027) 5.1.3 Global End-Stage Kidney Disease Treatment Sales Market Share by Application (2016-2027) 5.2 Global End-Stage Kidney Disease Treatment Revenue by Application 5.2.1 Global End-Stage Kidney Disease Treatment Historical Revenue by Application (2016-2021) 5.2.2 Global End-Stage Kidney Disease Treatment Forecasted Revenue by Application (2022-2027) 5.2.3 Global End-Stage Kidney Disease Treatment Revenue Market Share by Application (2016-2027) 5.3 Global End-Stage Kidney Disease Treatment Price by Application 5.3.1 Global End-Stage Kidney Disease Treatment Price by Application (2016-2021) 5.3.2 Global End-Stage Kidney Disease Treatment Price Forecast by Application (2022-2027) 6 North America 6.1 North America End-Stage Kidney Disease Treatment Market Size by Type 6.1.1 North America End-Stage Kidney Disease Treatment Sales by Type (2016-2027) 6.1.2 North America End-Stage Kidney Disease Treatment Revenue by Type (2016-2027) 6.2 North America End-Stage Kidney Disease Treatment Market Size by Application 6.2.1 North America End-Stage Kidney Disease Treatment Sales by Application (2016-2027) 6.2.2 North America End-Stage Kidney Disease Treatment Revenue by Application (2016-2027) 6.3 North America End-Stage Kidney Disease Treatment Market Size by Country 6.3.1 North America End-Stage Kidney Disease Treatment Sales by Country (2016-2027) 6.3.2 North America End-Stage Kidney Disease Treatment Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe End-Stage Kidney Disease Treatment Market Size by Type 7.1.1 Europe End-Stage Kidney Disease Treatment Sales by Type (2017-2027) 7.1.2 Europe End-Stage Kidney Disease Treatment Revenue by Type (2017-2027) 7.2 Europe End-Stage Kidney Disease Treatment Market Size by Application 7.2.1 Europe End-Stage Kidney Disease Treatment Sales by Application (2017-2027) 7.2.2 Europe End-Stage Kidney Disease Treatment Revenue by Application (2017-2027) 7.3 Europe End-Stage Kidney Disease Treatment Market Size by Country 7.3.1 Europe End-Stage Kidney Disease Treatment Sales by Country (2017-2027) 7.3.2 Europe End-Stage Kidney Disease Treatment Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific End-Stage Kidney Disease Treatment Market Size by Type 8.1.1 Asia Pacific End-Stage Kidney Disease Treatment Sales by Type (2018-2027) 8.1.2 Asia Pacific End-Stage Kidney Disease Treatment Revenue by Type (2018-2027) 8.2 Asia Pacific End-Stage Kidney Disease Treatment Market Size by Application 8.2.1 Asia Pacific End-Stage Kidney Disease Treatment Sales by Application (2018-2027) 8.2.2 Asia Pacific End-Stage Kidney Disease Treatment Revenue by Application (2018-2027) 8.3 Asia Pacific End-Stage Kidney Disease Treatment Market Size by Region 8.3.1 Asia Pacific End-Stage Kidney Disease Treatment Sales by Region (2018-2027) 8.3.2 Asia Pacific End-Stage Kidney Disease Treatment Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America End-Stage Kidney Disease Treatment Market Size by Type 9.1.1 Latin America End-Stage Kidney Disease Treatment Sales by Type (2019-2027) 9.1.2 Latin America End-Stage Kidney Disease Treatment Revenue by Type (2019-2027) 9.2 Latin America End-Stage Kidney Disease Treatment Market Size by Application 9.2.1 Latin America End-Stage Kidney Disease Treatment Sales by Application (2019-2027) 9.2.2 Latin America End-Stage Kidney Disease Treatment Revenue by Application (2019-2027) 9.3 Latin America End-Stage Kidney Disease Treatment Market Size by Country 9.3.1 Latin America End-Stage Kidney Disease Treatment Sales by Country (2019-2027) 9.3.2 Latin America End-Stage Kidney Disease Treatment Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa End-Stage Kidney Disease Treatment Market Size by Type 6.1.1 Middle East and Africa End-Stage Kidney Disease Treatment Sales by Type (2016-2027) 6.1.2 Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Type (2016-2027) 6.2 Middle East and Africa End-Stage Kidney Disease Treatment Market Size by Application 6.2.1 Middle East and Africa End-Stage Kidney Disease Treatment Sales by Application (2016-2027) 6.2.2 Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Application (2016-2027) 6.3 Middle East and Africa End-Stage Kidney Disease Treatment Market Size by Country 6.3.1 Middle East and Africa End-Stage Kidney Disease Treatment Sales by Country (2016-2027) 6.3.2 Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 BLR Bio LLC 11.1.1 BLR Bio LLC Corporation Information 11.1.2 BLR Bio LLC Overview 11.1.3 BLR Bio LLC End-Stage Kidney Disease Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 BLR Bio LLC End-Stage Kidney Disease Treatment Product Description 11.1.5 BLR Bio LLC Related Developments 11.2 CTI BioPharma Corp 11.2.1 CTI BioPharma Corp Corporation Information 11.2.2 CTI BioPharma Corp Overview 11.2.3 CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 CTI BioPharma Corp End-Stage Kidney Disease Treatment Product Description 11.2.5 CTI BioPharma Corp Related Developments 11.3 F. Hoffmann-La Roche Ltd 11.3.1 F. Hoffmann-La Roche Ltd Corporation Information 11.3.2 F. Hoffmann-La Roche Ltd Overview 11.3.3 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Product Description 11.3.5 F. Hoffmann-La Roche Ltd Related Developments 11.4 Novartis AG 11.4.1 Novartis AG Corporation Information 11.4.2 Novartis AG Overview 11.4.3 Novartis AG End-Stage Kidney Disease Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Novartis AG End-Stage Kidney Disease Treatment Product Description 11.4.5 Novartis AG Related Developments 11.5 Prolong Pharmaceuticals LLC 11.5.1 Prolong Pharmaceuticals LLC Corporation Information 11.5.2 Prolong Pharmaceuticals LLC Overview 11.5.3 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Product Description 11.5.5 Prolong Pharmaceuticals LLC Related Developments 11.6 VESSL Therapeutics Ltd 11.6.1 VESSL Therapeutics Ltd Corporation Information 11.6.2 VESSL Therapeutics Ltd Overview 11.6.3 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Product Description 11.6.5 VESSL Therapeutics Ltd Related Developments 11.1 BLR Bio LLC 11.1.1 BLR Bio LLC Corporation Information 11.1.2 BLR Bio LLC Overview 11.1.3 BLR Bio LLC End-Stage Kidney Disease Treatment Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 BLR Bio LLC End-Stage Kidney Disease Treatment Product Description 11.1.5 BLR Bio LLC Related Developments 12 Value Chain and Sales Channels Analysis 12.1 End-Stage Kidney Disease Treatment Value Chain Analysis 12.2 End-Stage Kidney Disease Treatment Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 End-Stage Kidney Disease Treatment Production Mode & Process 12.4 End-Stage Kidney Disease Treatment Sales and Marketing 12.4.1 End-Stage Kidney Disease Treatment Sales Channels 12.4.2 End-Stage Kidney Disease Treatment Distributors 12.5 End-Stage Kidney Disease Treatment Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 End-Stage Kidney Disease Treatment Industry Trends 13.2 End-Stage Kidney Disease Treatment Market Drivers 13.3 End-Stage Kidney Disease Treatment Market Challenges 13.4 End-Stage Kidney Disease Treatment Market Restraints 14 Key Findings in The Global End-Stage Kidney Disease Treatment Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global End-Stage Kidney Disease Treatment Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of MK-3866 Table 3. Major Manufacturers of Pacritinib Table 4. Major Manufacturers of Sanguinate Table 5. Major Manufacturers of Tesidolumab Table 6. Major Manufacturers of Others Table 7. Global End-Stage Kidney Disease Treatment Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 8. Global End-Stage Kidney Disease Treatment Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 9. Global End-Stage Kidney Disease Treatment Sales by Region (2016-2021) & (K Pcs) Table 10. Global End-Stage Kidney Disease Treatment Sales Market Share by Region (2016-2021) Table 11. Global End-Stage Kidney Disease Treatment Sales by Region (2016-2021) & (K Pcs) Table 12. Global End-Stage Kidney Disease Treatment Sales Market Share by Region (2022-2027) Table 13. Global End-Stage Kidney Disease Treatment Revenue by Region (2016-2021) & (US$ Million) Table 14. Global End-Stage Kidney Disease Treatment Revenue Market Share by Region (2016-2021) Table 15. Global End-Stage Kidney Disease Treatment Revenue by Region (2022-2027) & (US$ Million) Table 16. Global End-Stage Kidney Disease Treatment Revenue Market Share by Region (2022-2027) Table 17. Global End-Stage Kidney Disease Treatment Sales by Manufacturers (2016-2021) & (K Pcs) Table 18. Global End-Stage Kidney Disease Treatment Sales Share by Manufacturers (2016-2021) Table 19. Global End-Stage Kidney Disease Treatment Revenue by Manufacturers (2016-2021) & (US$ Million) Table 20. Global End-Stage Kidney Disease Treatment Revenue Share by Manufacturers (2016-2021) Table 21. End-Stage Kidney Disease Treatment Price by Manufacturers 2016-2021 (USD/Pcs) Table 22. Global End-Stage Kidney Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Global End-Stage Kidney Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End-Stage Kidney Disease Treatment as of 2020) Table 24. End-Stage Kidney Disease Treatment Manufacturing Base Distribution and Headquarters Table 25. Manufacturers End-Stage Kidney Disease Treatment Product Offered Table 26. Date of Manufacturers Enter into End-Stage Kidney Disease Treatment Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global End-Stage Kidney Disease Treatment Sales by Type (2016-2021) & (K Pcs) Table 29. Global End-Stage Kidney Disease Treatment Sales by Type (2022-2027) & (K Pcs) Table 30. Global End-Stage Kidney Disease Treatment Sales Share by Type (2016-2021) Table 31. Global End-Stage Kidney Disease Treatment Sales Share by Type (2022-2027) Table 32. Global End-Stage Kidney Disease Treatment Revenue by Type (2016-2021) & (US$ Million) Table 33. Global End-Stage Kidney Disease Treatment Revenue by Type (2022-2027) & (US$ Million) Table 34. Global End-Stage Kidney Disease Treatment Revenue Share by Type (2016-2021) Table 35. Global End-Stage Kidney Disease Treatment Revenue Share by Type (2022-2027) Table 36. End-Stage Kidney Disease Treatment Price by Type (2016-2021) & (USD/Pcs) Table 37. Global End-Stage Kidney Disease Treatment Price Forecast by Type (2022-2027) & (USD/Pcs) Table 38. Global End-Stage Kidney Disease Treatment Sales by Application (2016-2021) & (K Pcs) Table 39. Global End-Stage Kidney Disease Treatment Sales by Application (2022-2027) & (K Pcs) Table 40. Global End-Stage Kidney Disease Treatment Sales Share by Application (2016-2021) Table 41. Global End-Stage Kidney Disease Treatment Sales Share by Application (2022-2027) Table 42. Global End-Stage Kidney Disease Treatment Revenue by Application (2016-2021) & (US$ Million) Table 43. Global End-Stage Kidney Disease Treatment Revenue by Application (2022-2027) & (US$ Million) Table 44. Global End-Stage Kidney Disease Treatment Revenue Share by Application (2016-2021) Table 45. Global End-Stage Kidney Disease Treatment Revenue Share by Application (2022-2027) Table 46. End-Stage Kidney Disease Treatment Price by Application (2016-2021) & (USD/Pcs) Table 47. Global End-Stage Kidney Disease Treatment Price Forecast by Application (2022-2027) & (USD/Pcs) Table 48. North America End-Stage Kidney Disease Treatment Sales by Type (2016-2021) & (K Pcs) Table 49. North America End-Stage Kidney Disease Treatment Sales by Type (2022-2027) & (K Pcs) Table 50. North America End-Stage Kidney Disease Treatment Revenue by Type (2016-2021) & (US$ Million) Table 51. North America End-Stage Kidney Disease Treatment Revenue by Type (2022-2027) & (US$ Million) Table 52. North America End-Stage Kidney Disease Treatment Sales by Application (2016-2021) & (K Pcs) Table 53. North America End-Stage Kidney Disease Treatment Sales by Application (2022-2027) & (K Pcs) Table 54. North America End-Stage Kidney Disease Treatment Revenue by Application (2016-2021) & (US$ Million) Table 55. North America End-Stage Kidney Disease Treatment Revenue by Application (2022-2027) & (US$ Million) Table 56. North America End-Stage Kidney Disease Treatment Sales by Country (2016-2021) & (K Pcs) Table 57. North America End-Stage Kidney Disease Treatment Sales by Country (2022-2027) & (K Pcs) Table 58. North America End-Stage Kidney Disease Treatment Revenue by Country (2016-2021) & (US$ Million) Table 59. North America End-Stage Kidney Disease Treatment Revenue by Country (2022-2027) & (US$ Million) Table 60. Europe End-Stage Kidney Disease Treatment Sales by Type (2016-2021) & (K Pcs) Table 61. Europe End-Stage Kidney Disease Treatment Sales by Type (2022-2027) & (K Pcs) Table 62. Europe End-Stage Kidney Disease Treatment Revenue by Type (2016-2021) & (US$ Million) Table 63. Europe End-Stage Kidney Disease Treatment Revenue by Type (2022-2027) & (US$ Million) Table 64. Europe End-Stage Kidney Disease Treatment Sales by Application (2016-2021) & (K Pcs) Table 65. Europe End-Stage Kidney Disease Treatment Sales by Application (2022-2027) & (K Pcs) Table 66. Europe End-Stage Kidney Disease Treatment Revenue by Application (2016-2021) & (US$ Million) Table 67. Europe End-Stage Kidney Disease Treatment Revenue by Application (2022-2027) & (US$ Million) Table 68. Europe End-Stage Kidney Disease Treatment Sales by Country (2016-2021) & (K Pcs) Table 69. Europe End-Stage Kidney Disease Treatment Sales by Country (2022-2027) & (K Pcs) Table 70. Europe End-Stage Kidney Disease Treatment Revenue by Country (2016-2021) & (US$ Million) Table 71. Europe End-Stage Kidney Disease Treatment Revenue by Country (2022-2027) & (US$ Million) Table 72. Asia Pacific End-Stage Kidney Disease Treatment Sales by Type (2016-2021) & (K Pcs) Table 73. Asia Pacific End-Stage Kidney Disease Treatment Sales by Type (2022-2027) & (K Pcs) Table 74. Asia Pacific End-Stage Kidney Disease Treatment Revenue by Type (2016-2021) & (US$ Million) Table 75. Asia Pacific End-Stage Kidney Disease Treatment Revenue by Type (2022-2027) & (US$ Million) Table 76. Asia Pacific End-Stage Kidney Disease Treatment Sales by Application (2016-2021) & (K Pcs) Table 77. Asia Pacific End-Stage Kidney Disease Treatment Sales by Application (2022-2027) & (K Pcs) Table 78. Asia Pacific End-Stage Kidney Disease Treatment Revenue by Application (2016-2021) & (US$ Million) Table 79. Asia Pacific End-Stage Kidney Disease Treatment Revenue by Application (2022-2027) & (US$ Million) Table 80. Asia Pacific End-Stage Kidney Disease Treatment Sales by Region (2016-2021) & (K Pcs) Table 81. Asia Pacific End-Stage Kidney Disease Treatment Sales by Region (2022-2027) & (K Pcs) Table 82. Asia Pacific End-Stage Kidney Disease Treatment Revenue by Region (2016-2021) & (US$ Million) Table 83. Asia Pacific End-Stage Kidney Disease Treatment Revenue by Region (2022-2027) & (US$ Million) Table 84. Latin America End-Stage Kidney Disease Treatment Sales by Type (2016-2021) & (K Pcs) Table 85. Latin America End-Stage Kidney Disease Treatment Sales by Type (2022-2027) & (K Pcs) Table 86. Latin America End-Stage Kidney Disease Treatment Revenue by Type (2016-2021) & (US$ Million) Table 87. Latin America End-Stage Kidney Disease Treatment Revenue by Type (2022-2027) & (US$ Million) Table 88. Latin America End-Stage Kidney Disease Treatment Sales by Application (2016-2021) & (K Pcs) Table 89. Latin America End-Stage Kidney Disease Treatment Sales by Application (2022-2027) & (K Pcs) Table 90. Latin America End-Stage Kidney Disease Treatment Revenue by Application (2016-2021) & (US$ Million) Table 91. Latin America End-Stage Kidney Disease Treatment Revenue by Application (2022-2027) & (US$ Million) Table 92. Latin America End-Stage Kidney Disease Treatment Sales by Country (2016-2021) & (K Pcs) Table 93. Latin America End-Stage Kidney Disease Treatment Sales by Country (2022-2027) & (K Pcs) Table 94. Latin America End-Stage Kidney Disease Treatment Revenue by Country (2016-2021) & (US$ Million) Table 95. Latin America End-Stage Kidney Disease Treatment Revenue by Country (2022-2027) & (US$ Million) Table 96. Middle East and Africa End-Stage Kidney Disease Treatment Sales by Type (2016-2021) & (K Pcs) Table 97. Middle East and Africa End-Stage Kidney Disease Treatment Sales by Type (2022-2027) & (K Pcs) Table 98. Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Type (2016-2021) & (US$ Million) Table 99. Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Type (2022-2027) & (US$ Million) Table 100. Middle East and Africa End-Stage Kidney Disease Treatment Sales by Application (2016-2021) & (K Pcs) Table 101. Middle East and Africa End-Stage Kidney Disease Treatment Sales by Application (2022-2027) & (K Pcs) Table 102. Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Application (2016-2021) & (US$ Million) Table 103. Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Application (2022-2027) & (US$ Million) Table 104. Middle East and Africa End-Stage Kidney Disease Treatment Sales by Country (2016-2021) & (K Pcs) Table 105. Middle East and Africa End-Stage Kidney Disease Treatment Sales by Country (2022-2027) & (K Pcs) Table 106. Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa End-Stage Kidney Disease Treatment Revenue by Country (2022-2027) & (US$ Million) Table 108. BLR Bio LLC Corporation Information Table 109. BLR Bio LLC Description and Major Businesses Table 110. BLR Bio LLC End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 111. BLR Bio LLC End-Stage Kidney Disease Treatment Product Table 112. BLR Bio LLC Recent Developments Table 113. CTI BioPharma Corp Corporation Information Table 114. CTI BioPharma Corp Description and Major Businesses Table 115. CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 116. CTI BioPharma Corp End-Stage Kidney Disease Treatment Product Table 117. CTI BioPharma Corp Recent Developments Table 118. F. Hoffmann-La Roche Ltd Corporation Information Table 119. F. Hoffmann-La Roche Ltd Description and Major Businesses Table 120. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 121. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Product Table 122. F. Hoffmann-La Roche Ltd Recent Developments Table 123. Novartis AG Corporation Information Table 124. Novartis AG Description and Major Businesses Table 125. Novartis AG End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 126. Novartis AG End-Stage Kidney Disease Treatment Product Table 127. Novartis AG Recent Developments Table 128. Prolong Pharmaceuticals LLC Corporation Information Table 129. Prolong Pharmaceuticals LLC Description and Major Businesses Table 130. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 131. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Product Table 132. Prolong Pharmaceuticals LLC Recent Developments Table 133. VESSL Therapeutics Ltd Corporation Information Table 134. VESSL Therapeutics Ltd Description and Major Businesses Table 135. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 136. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Product Table 137. VESSL Therapeutics Ltd Recent Developments Table 138. Key Raw Materials Lists Table 139. Raw Materials Key Suppliers Lists Table 140. End-Stage Kidney Disease Treatment Distributors List Table 141. End-Stage Kidney Disease Treatment Customers List Table 142. End-Stage Kidney Disease Treatment Market Trends Table 143. End-Stage Kidney Disease Treatment Market Drivers Table 144. End-Stage Kidney Disease Treatment Market Challenges Table 145. End-Stage Kidney Disease Treatment Market Restraints Table 146. Research Programs/Design for This Report Table 147. Key Data Information from Secondary Sources Table 148. Key Data Information from Primary Sources List of Figures Figure 1. End-Stage Kidney Disease Treatment Product Picture Figure 2. Global End-Stage Kidney Disease Treatment Market Share by Type in 2020 & 2027 Figure 3. MK-3866 Product Picture Figure 4. Pacritinib Product Picture Figure 5. Sanguinate Product Picture Figure 6. Tesidolumab Product Picture Figure 7. Others Product Picture Figure 8. Global End-Stage Kidney Disease Treatment Sales Market Share by Application in 2020 & 2027 Figure 9. Clinic Figure 10. Hospital Figure 11. Others Figure 12. End-Stage Kidney Disease Treatment Report Years Considered Figure 13. Global End-Stage Kidney Disease Treatment Sales 2016-2027 (K Pcs) Figure 14. Global End-Stage Kidney Disease Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global End-Stage Kidney Disease Treatment Revenue 2016-2027 (US$ Million) Figure 16. Global End-Stage Kidney Disease Treatment Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 17. Global End-Stage Kidney Disease Treatment Sales Market Share by Region (2016-2021) Figure 18. Global End-Stage Kidney Disease Treatment Sales Market Share by Region (2022-2027) Figure 19. North America End-Stage Kidney Disease Treatment Sales YoY (2016-2027) & (K Pcs) Figure 20. North America End-Stage Kidney Disease Treatment Revenue YoY (2016-2027) & (US$ Million) Figure 21. Europe End-Stage Kidney Disease Treatment Sales YoY (2016-2027) & (K Pcs) Figure 22. Europe End-Stage Kidney Disease Treatment Revenue YoY (2016-2027) & (US$ Million) Figure 23. Asia-Pacific End-Stage Kidney Disease Treatment Sales YoY (2016-2027) & (K Pcs) Figure 24. Asia-Pacific End-Stage Kidney Disease Treatment Revenue YoY (2016-2027) & (US$ Million) Figure 25. Latin America End-Stage Kidney Disease Treatment Sales YoY (2016-2027) & (K Pcs) Figure 26. Latin America End-Stage Kidney Disease Treatment Revenue YoY (2016-2027) & (US$ Million) Figure 27. Middle East & Africa End-Stage Kidney Disease Treatment Sales YoY (2016-2027) & (K Pcs) Figure 28. Middle East & Africa End-Stage Kidney Disease Treatment Revenue YoY (2016-2027) & (US$ Million) Figure 29. The Top 10 and Top 5 Players Market Share by End-Stage Kidney Disease Treatment Sales in 2020 Figure 30. The Top 10 and Top 5 Players Market Share by End-Stage Kidney Disease Treatment Revenue in 2020 Figure 31. End-Stage Kidney Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 32. Global End-Stage Kidney Disease Treatment Sales Market Share by Type (2016-2027) Figure 33. Global End-Stage Kidney Disease Treatment Revenue Market Share by Type (2016-2027) Figure 34. Global End-Stage Kidney Disease Treatment Sales Market Share by Application (2016-2027) Figure 35. Global End-Stage Kidney Disease Treatment Revenue Market Share by Application (2016-2027) Figure 36. North America End-Stage Kidney Disease Treatment Sales Market Share by Type (2016-2027) Figure 37. North America End-Stage Kidney Disease Treatment Revenue Market Share by Type (2016-2027) Figure 38. North America End-Stage Kidney Disease Treatment Sales Market Share by Application (2016-2027) Figure 39. North America End-Stage Kidney Disease Treatment Revenue Market Share by Application (2016-2027) Figure 40. North America End-Stage Kidney Disease Treatment Sales Share by Country (2016-2027) Figure 41. North America End-Stage Kidney Disease Treatment Revenue Share by Country (2016-2027) Figure 42. U.S. End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 43. Canada End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 44. Europe End-Stage Kidney Disease Treatment Sales Market Share by Type (2016-2027) Figure 45. Europe End-Stage Kidney Disease Treatment Revenue Market Share by Type (2016-2027) Figure 46. Europe End-Stage Kidney Disease Treatment Sales Market Share by Application (2016-2027) Figure 47. Europe End-Stage Kidney Disease Treatment Revenue Market Share by Application (2016-2027) Figure 48. Europe End-Stage Kidney Disease Treatment Sales Share by Country (2016-2027) Figure 49. Europe End-Stage Kidney Disease Treatment Revenue Share by Country (2016-2027) Figure 50. Germany End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 51. France End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 52. U.K. End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 53. Italy End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 54. Russia End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 55. Asia Pacific End-Stage Kidney Disease Treatment Sales Market Share by Type (2016-2027) Figure 56. Asia Pacific End-Stage Kidney Disease Treatment Revenue Market Share by Type (2016-2027) Figure 57. Asia Pacific End-Stage Kidney Disease Treatment Sales Market Share by Application (2016-2027) Figure 58. Asia Pacific End-Stage Kidney Disease Treatment Revenue Market Share by Application (2016-2027) Figure 59. Asia Pacific End-Stage Kidney Disease Treatment Sales Share by Region (2016-2027) Figure 60. Asia Pacific End-Stage Kidney Disease Treatment Revenue Share by Region (2016-2027) Figure 61. China End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 62. Japan End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 63. South Korea End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 64. India End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 65. Australia End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 66. Taiwan End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 67. Indonesia End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 68. Thailand End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 69. Malaysia End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 70. Philippines End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 71. Latin America End-Stage Kidney Disease Treatment Sales Market Share by Type (2016-2027) Figure 72. Latin America End-Stage Kidney Disease Treatment Revenue Market Share by Type (2016-2027) Figure 73. Latin America End-Stage Kidney Disease Treatment Sales Market Share by Application (2016-2027) Figure 74. Latin America End-Stage Kidney Disease Treatment Revenue Market Share by Application (2016-2027) Figure 75. Latin America End-Stage Kidney Disease Treatment Sales Share by Country (2016-2027) Figure 76. Latin America End-Stage Kidney Disease Treatment Revenue Share by Country (2016-2027) Figure 77. Mexico End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 78. Brazil End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 79. Argentina End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 80. Middle East and Africa End-Stage Kidney Disease Treatment Sales Market Share by Type (2016-2027) Figure 81. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Market Share by Type (2016-2027) Figure 82. Middle East and Africa End-Stage Kidney Disease Treatment Sales Market Share by Application (2016-2027) Figure 83. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Market Share by Application (2016-2027) Figure 84. Middle East and Africa End-Stage Kidney Disease Treatment Sales Share by Country (2016-2027) Figure 85. Middle East and Africa End-Stage Kidney Disease Treatment Revenue Share by Country (2016-2027) Figure 86. Turkey End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 87. Saudi Arabia End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 88. U.A.E End-Stage Kidney Disease Treatment Revenue (2016-2027) & (US$ Million) Figure 89. End-Stage Kidney Disease Treatment Value Chain Figure 90. End-Stage Kidney Disease Treatment Production Process Figure 91. Channels of Distribution Figure 92. Distributors Profiles Figure 93. Bottom-up and Top-down Approaches for This Report Figure 94. Data Triangulation Figure 95. Key Executives Interviewed

BLR Bio LLC CTI BioPharma Corp F. Hoffmann-La Roche Ltd Novartis AG Prolong Pharmaceuticals LLC VESSL Therapeutics Ltd